- Whole Blood
- Blood Components
- Blood Derivatives
Blood Products Market size was valued at USD 35506 million in 2022 and is poised to grow at a CAGR of 4.4% from 2023 - 2029. has plentiful of market players and it is consolidated. In terms of processing devices, strong market players are present. Companies in this market are focusing on new product developments and market expansions for strengthen their market share. These are classified blood components arranged in the blood transfusion focus (red cells, platelets, crisp solidified plasma and cryoprecipitate) or plasma subsidiaries produced from pooled plasma gifts in plasma fractionation focuses, (for example, egg whites, coagulation components and immunoglobulins). Furthermore companies are also strengthening their position by acquiring the other companies operating in same market.
Blood Products Market Key Developments:
- In August 2012, Haemonetics Corporation acquired business assets of blood collection, filteration and processing product lines of Pall Corpration.
- On November 11, 2013, Grifols, a global healthcare company and producer of plasma therapies, acquired the transfusion diagnostics unit of Novartis. Furthermore, government organizations and non-government organizations are also playing major role in providing awareness regarding life threatening diseases, blood transfusion, blood donation etc.
Blood Products Market Summary
Study Period
2024-2030Base Year
2023CAGR
4.4%Largest Market
North AmericaFastest Growing Market
Asia PacificBlood Products Market Dynamics
Increase in the prevalance of various diseases, expanded need of blood during several surgical procedurs, increse in government initiatives regarding necessity of blood donation, safety of blood transfusion, several blood donating campaigns are some of the factors that are fuelling the growth of the blood products market. However, Lack of awareness and lack of skilled and trained professionals can lead to misleading transfusion thus, declining the sales of blood products globally.
North-America Got Significant Share
Blood Products Market Regional Analysis
Geographically blood products market is segmented as Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe. North America is expected to have major share in blood products market owing to the factors such as growing rates of blood donation and transfusion, increase in R&D in blood and blood products and growing awareness on blood infectious diseases, increase in doctor visiting, growing prevalence of chronic diseases such cardiovascular diseases and cancers etc. However, the Asian market is expected to grow significantly during the forecast period. The increasing prevalence and incidence rate of chronic disorders in Asia provides growth opportunities for players in the market. Key players are focusing on strategies such as product launches and acquisitions to strengthen their foothold in the blood products market.
Latin America
Europe
Asia Pacific
Middle East
North America
Blood Products Market Segmentation
By Type
By Product
- Packed RBCs
- Platelets
- FFP
- Cryo
- Washed Red Blood Cells
- Irradiated Blood
By Application
- Treatment
- Diagnosis
By End User
- Blood Banks
- Diagnostic Centres
- Hospitals
Frequently Asked Questions
The blood products market size was valued at USD 35506 million in 2023. and is poised to grow at a CAGR of 4.4% from 2024 - 2030
The blood products market key players are: Grifols (Spain) Medtronic (US) Becton, Dickinson and Company (US) Fresenius (Germany) Terumo (Japan) Haemonetics (US) Kawasumi Laboratories (Japan) Nipro Medical (US) Greiner Holding (Austria)
The blood products market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
Key Features of the Report
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
| 1. Executive Summary |
| 2. Global Blood Products Market Introduction |
| 2.1.Global Blood Products Market - Taxonomy |
| 2.2.Global Blood Products Market - Definitions |
| 2.2.1. Type |
| 2.2.2.Product |
| 2.2.3.Application |
| 2.2.4.End User |
| 2.2.5.Region |
| 3.Global Blood Products Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Blood Products Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Blood Products Market By Type , 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Whole Blood |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Blood Components |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Blood Derivatives |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Global Blood Products Market By Product, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Packed RBCs |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Platelets |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. FFP |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Cryo |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Washed Red Blood Cells |
| 6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Irradiated Blood |
| 6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 7. Global Blood Products Market By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. Treatment |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Diagnosis |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 8. Global Blood Products Market By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. Blood Banks |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Diagnostic Centres |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Hospitals |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9. Global Blood Products Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10. North America Blood Products Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Whole Blood |
| 10.1.2.Blood Components |
| 10.1.3.Blood Derivatives |
| 10.2. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Packed RBCs |
| 10.2.2.Platelets |
| 10.2.3.FFP |
| 10.2.4.Cryo |
| 10.2.5.Washed Red Blood Cells |
| 10.2.6.Irradiated Blood |
| 10.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Treatment |
| 10.3.2.Diagnosis |
| 10.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Blood Banks |
| 10.4.2.Diagnostic Centres |
| 10.4.3.Hospitals |
| 10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11. Europe Blood Products Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Whole Blood |
| 11.1.2.Blood Components |
| 11.1.3.Blood Derivatives |
| 11.2. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Packed RBCs |
| 11.2.2.Platelets |
| 11.2.3.FFP |
| 11.2.4.Cryo |
| 11.2.5.Washed Red Blood Cells |
| 11.2.6.Irradiated Blood |
| 11.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Treatment |
| 11.3.2.Diagnosis |
| 11.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Blood Banks |
| 11.4.2.Diagnostic Centres |
| 11.4.3.Hospitals |
| 11.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12. Asia Pacific (APAC) Blood Products Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Whole Blood |
| 12.1.2.Blood Components |
| 12.1.3.Blood Derivatives |
| 12.2. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Packed RBCs |
| 12.2.2.Platelets |
| 12.2.3.FFP |
| 12.2.4.Cryo |
| 12.2.5.Washed Red Blood Cells |
| 12.2.6.Irradiated Blood |
| 12.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Treatment |
| 12.3.2.Diagnosis |
| 12.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Blood Banks |
| 12.4.2.Diagnostic Centres |
| 12.4.3.Hospitals |
| 12.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13. Middle East and Africa (MEA) Blood Products Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Whole Blood |
| 13.1.2.Blood Components |
| 13.1.3.Blood Derivatives |
| 13.2. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Packed RBCs |
| 13.2.2.Platelets |
| 13.2.3.FFP |
| 13.2.4.Cryo |
| 13.2.5.Washed Red Blood Cells |
| 13.2.6.Irradiated Blood |
| 13.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Treatment |
| 13.3.2.Diagnosis |
| 13.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Blood Banks |
| 13.4.2.Diagnostic Centres |
| 13.4.3.Hospitals |
| 13.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14. Latin America Blood Products Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 14.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Whole Blood |
| 14.1.2.Blood Components |
| 14.1.3.Blood Derivatives |
| 14.2. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Packed RBCs |
| 14.2.2.Platelets |
| 14.2.3.FFP |
| 14.2.4.Cryo |
| 14.2.5.Washed Red Blood Cells |
| 14.2.6.Irradiated Blood |
| 14.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Treatment |
| 14.3.2.Diagnosis |
| 14.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Blood Banks |
| 14.4.2.Diagnostic Centres |
| 14.4.3.Hospitals |
| 14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Grifols (Spain) |
| 15.2.2.Medtronic (US) |
| 15.2.3.Becton, Dickinson and Company (US) |
| 15.2.4.Fresenius (Germany) |
| 15.2.5.Terumo (Japan) |
| 15.2.6.Haemonetics (US) |
| 15.2.7.Kawasumi Laboratories (Japan) |
| 15.2.8.Nipro Medical (US) |
| 15.2.9.Greiner Holding (Austria) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
- Grifols (Spain)
- Medtronic (US)
- Becton, Dickinson and Company (US)
- Fresenius (Germany)
- Terumo (Japan)
- Haemonetics (US)
- Kawasumi Laboratories (Japan)
- Nipro Medical (US)
- Greiner Holding (Austria)